THE TAPE
$173.02▲ +1.90%
Last close
Relative strength
77RS
of 99, against every stock▲ +16 on the month
Powering up
Unconfirmed
+21.3%
six months against the S&P 500
52-week range
−0.3%
from the high
$137.62$173.57
Setup
multi yearfresh breakout
+1.2%
against the pivot at $170.99
No report date on the calendar.
Growth FLATProof SHOWN
Quarter to Sep 30, revenue +4% on a year ago
11/16 O 172.16 H 173.57 L 171.93 Vol 15.0M
Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

All four are in order, fastest above slowest — every timeframe pointing the same way.

RS77
vs pivot+1.19%
Tightening0.78×
Dry-up0.98×
Up/down vol0.24
From high0%
fresh breakout6 of 9checks
Powering up
Support and resistance
Support below
$153.57
-11.2% · tested 5× · last 78 sessions ago
Resistance above
None within the last 120 sessions

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

The base has run 73.6 weeks and fell 20% from its ceiling at its deepest. The pivot is $170.99, and the stock closed 1.2% above that pivot. Its relative strength rating is 77.

Against its industry
UnconfirmedNone of the patterns above holds.
One month against the S&P 500
+12.0%
Three months against the S&P 500
+25.1%
Six months against the S&P 500
+21.3%

Its industry has too few members to make an index of, so it is read against the S&P 500 and can only be turning, caution or unconfirmed.

Also on
Peers
Catalyst roadmap

Nothing dated in the next three months that we can ingest automatically.

How it moves on earnings

On average 2.4% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$87.9B
+4.0% year on year
Operating margin
22.6%
Net margin
18.2%
Free cash flow
$15.3B
3.8% of market cap
Price to sales
4.56×
Price to earnings
25.0×

Twelve months to Sep 30, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Oct 22
Key takeaway
Profitable and cash generating; the question is growth.
Revenue
$23.3B
+9.8% QoQ · +4.0% YoY
Gross margin
—
Net income
$4.7B
Positive
Free cash flow
$4.4B
Cash generating

What the numbers say

  • Revenue +4.0% year over year, +9.8% on the quarter
  • Good: Profitable: net income $4.73B, operating margin 25.5%
  • Good: Cash generating: operating cash flow $5.77B, free cash flow $4.40B
  • Net debt $23.56B · cash $15.37B
Revenue by quarter
Free cash flow
Net income
shares -1.2% in a year · net debt $23.6B

What is not obvious

  • Weak: Debt $38.92B, +14% on the quarter; 0.4× trailing revenue

The desk’s own read

Flagged as drifting up since the report

Final read
Growth: FLAT · Economic proof: SHOWN
Key question: Can the cash generation hold as growth slows?
The next test is whether the quarter repeats.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

Held by 3 of 46 tracked funds at the end of Q3 2026.

Last quarter: 1 bought new, 1 added, 1 trimmed.

Checking your subscription…

From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.

Flagged by the market sweep
Closed above its 20- and 50-day on heavy volumeTape · 2026-11-06
above 20d & 50d on 1.7x volume at 167.10
Mixed: stocks have outrun random stocks by 0.2% over three sessions, not consistently enough to call (1,668 cases over 60 nights). Against their own sector they have lagged by 0.7%.
Reported resultsFiling · 2026-10-23
2.02
No measurable effect: stocks behave like random ones over the next three sessions (2,340 cases over 54 nights).
Moved 5%+ up on earningsTape · 2026-10-23
+5.6% on earnings 2026-10-22
No measurable effect: stocks behave like random ones over the next three sessions (604 cases over 42 nights).
New 52-week highTape · 2026-10-22
2.5x vol
Mixed: stocks have lagged random stocks by 0.9% over three sessions, not consistently enough to call (554 cases over 52 nights). Against their own sector they have lagged by 2.1%.
GappedTape · 2026-10-22
+5.6%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Unusual volumeTape · 2026-10-22
4.7 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.
Earnings comingEvent · 2026-10-21
reports 2026-10-22 bmo
No measurable effect: stocks behave like random ones over the next three sessions (2,970 cases over 40 nights).

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders
Bought on the open market
0
Sold on the open market
28
$38,010,135 total

Sold: Abd El Hak Hesham, Schulten Andre, Santos de Azevedo Juliana Monteiro, Janzaruk Matthew W., Gama Paul, Aguilar Moses Victor Javier, Raman Sundar G., Jejurikar Shailesh, Purushothaman Balaji, Whaley Susan Street, Bharucha Freddy P., Pritchard Marc S..

Not counted above: 48 filings for awards, option exercises, gifts or shares withheld to pay tax. Those follow a vesting schedule nobody chose the timing of, and counting them as selling is how that number gets misread.

Most recent filings
2026-11-12 Abd El Hak Hesham · CEO-Baby and Feminine Caresell2,250$379,058
2026-11-05 Schulten Andre · Chief Financial Officeroption exercise30,677$2,408,758
2026-11-05 Schulten Andre · Chief Financial Officersell30,677$5,184,413
2026-11-05 Santos de Azevedo Juliana Monteiro · CEO - Groomingsell5,370$907,530
2026-11-04 Schulten Andre · Chief Financial Officeroption exercise33,624$3,062,138
2026-11-04 Schulten Andre · Chief Financial Officersell33,624$5,547,960
2026-11-03 Janzaruk Matthew W. · SVP - Chief Accounting Officeroption exercise9,479$934,155
2026-11-03 Janzaruk Matthew W. · SVP - Chief Accounting Officersell9,479$1,545,077

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

What lines up

6 of 9 published checks currently line up. This is a count, not a probability — nothing on this site measures how often a setup works.

Relative strength of 80 or better
Above its 50-day line
Above its 200-day line
Averages fully stacked
Within 5% of its pivot
Range tightening through the base
Volume drying up through the base
More up-volume than down-volume
Within 15% of its 52-week high
What analysts expect
Strong buy5
Buy9
Hold10
Sell0
Strong sell1

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.

X-ray

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Procter & Gamble Company (PG) — The Tape